Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
about
Mesalamine in the treatment and maintenance of remission of ulcerative colitisNovel study designs to investigate the placebo response.Therapeutic efficacy of pH-dependent release formulation of mesalazine on active ulcerative colitis resistant to time-dependent release formulation: analysis of fecal calprotectin concentrationUpdate on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitisDrug development in inflammatory bowel disease: the role of the FDA.Topical therapies in inflammatory bowel disease.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels.Dissolution of Commercially Available Mesalamine Formulations at Various pH Levels.Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.Once-daily mesalamine granules for ulcerative colitis.Topical therapy is underused in patients with ulcerative colitis.
P2860
Q26865546-F01D4ED0-4817-4DD8-BE19-E5BB9F4589A0Q33929541-E4106E8A-499C-421D-995C-AD07CF62CB5FQ34608415-A84D5EA0-0CE8-4205-AAA1-4C40747E4EA6Q36144377-4B791D80-9F7E-474A-8DBB-327A560853F7Q37109690-F6015B1C-5FC1-4079-B1A6-8000B5D493B1Q37864253-4BB64603-216B-458D-BA62-E9D2A7213080Q38050885-4013E040-49E2-48CA-AE7E-660523E07834Q38973323-158000BC-DD7E-4477-98D6-B127C76E2251Q41405258-9026A864-6700-4460-945C-1A77C1F442E9Q41518791-391A11EE-D4B3-40B3-B633-BB1F71C72F3BQ42923681-D0B1F2E4-5D00-4314-9189-6FE7F67226D6Q42995730-63EBD01F-FFEB-40F0-A978-A300BFD76A0BQ44237715-62770C68-17A3-49A9-B343-A85C8EE17937
P2860
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@en
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@nl
type
label
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@en
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@nl
prefLabel
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@en
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@nl
P2860
P1433
P1476
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
@en
P2093
Alan C Moss
Nielsen Q Fernandez-Becker
P2860
P304
P356
10.2165/00003495-200868080-00006
P577
2008-01-01T00:00:00Z
P6179
1011626970